Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in patient- and tumor characteristics, treatment and survival between patients with screen-detected versus clinically detected colorectal peritoneal metastases.
Galanos LJK, Rijken A, Elferink MAG, Boerma D, Brandt-Kerkhof A, de Reuver PR, Tuynman JB, Kok NFM, Hemmer PHJ, van Grevenstein WMU, Huysentruyt C, van Erning FN, de Hingh IHJT. Galanos LJK, et al. Among authors: hemmer phj. Eur J Surg Oncol. 2024 Oct 25;51(1):108789. doi: 10.1016/j.ejso.2024.108789. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39500234
An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry.
van Erning FN, van den Heuvel TBM, Sijtsma FPC, Boerma D, Brandt-Kerkhof ARM, Bremers AJ, van Duyn EB, van Grevenstein HMU, Hemmer PHJ, Kok NFM, Madsen E, de Reuver PR, Wiezer RJ, Witkamp AJ, Nienhuijs SW, Poelmann FB, Tuynman JB, Been LB, Rovers KP, de Hingh IHJT. van Erning FN, et al. Among authors: hemmer phj. Eur J Surg Oncol. 2024 Aug 14;50(12):108568. doi: 10.1016/j.ejso.2024.108568. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39241538
Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Dietz MV, Hannink G, Said I, van der Zant FA, van de Vlasakker VCJ, Brandt-Kerkhof ARM, Verhoef C, Bremers AJA, de Wilt JHW, Hemmer PHJ, de Hingh IHJT, de Reuver PR, Madsen EVE. Dietz MV, et al. Among authors: hemmer phj. Eur J Surg Oncol. 2024 Jun;50(6):108294. doi: 10.1016/j.ejso.2024.108294. Epub 2024 Apr 4. Eur J Surg Oncol. 2024. PMID: 38583215 Free article.
Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases: A Nationwide Population-Based Study.
van der Ven RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, Boerma D, van Grevenstein WMU, Hemmer PHJ, Kok NFM, Madsen EVE, de Reuver P, Tuynman JB, van Erning FN, de Hingh IHJT. van der Ven RGFM, et al. Among authors: hemmer phj. Ann Surg Oncol. 2024 Jun;31(6):3758-3768. doi: 10.1245/s10434-024-15131-0. Epub 2024 Mar 7. Ann Surg Oncol. 2024. PMID: 38453767 Free PMC article.
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
Zwanenburg ES, El Klaver C, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, Brandt-Kerkhof ARM, Bremers AJA, Burger PJWA, Fabry HFJ, Ferenschild FTJ, Festen S, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Kusters M, Musters GD, Schoonderwoerd L, Tuynman JB, van de Ven AWH, van Westreenen HL, Wiezer MJ, Zimmerman DDE, van Zweeden A, Dijkgraaf MGW, Tanis PJ; COLOPEC Collaborators Group; COLOOPEC Collaborators Group. Zwanenburg ES, et al. Among authors: hemmer phj. J Clin Oncol. 2024 Jan 10;42(2):140-145. doi: 10.1200/JCO.22.02644. Epub 2023 Nov 3. J Clin Oncol. 2024. PMID: 37922442 Clinical Trial.
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.
Bakkers C, Rovers KP, Rijken A, Simkens GAAM, Bonhof CS, Nienhuijs SW, Burger JWA, Creemers GJM, Brandt-Kerkhof ARM, Tuynman JB, Aalbers AGJ, Wiezer MJ, de Reuver PR, van Grevenstein WMU, Hemmer PHJ, Punt CJA, Tanis PJ, Mols F, de Hingh IHJT; Dutch Peritoneal Oncology Group and the Dutch Colorectal Cancer Group. Bakkers C, et al. Among authors: hemmer phj. Ann Surg Oncol. 2023 May;30(5):2678-2688. doi: 10.1245/s10434-023-13116-z. Epub 2023 Feb 8. Ann Surg Oncol. 2023. PMID: 36754943 Free PMC article. Clinical Trial.
Impact of cumulative complications on 1-year treatment-related healthcare costs in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
van der Zant FA, Kooijman BJL, Hentzen JEKR, Helfrich W, Ploeg EM, van Ginkel RJ, van Leeuwen BL, Been LB, Klaase JM, Hemmer PHJ, van der Hilst CS, Kruijff S. van der Zant FA, et al. Among authors: hemmer phj. BJS Open. 2022 Sep 2;6(5):zrac109. doi: 10.1093/bjsopen/zrac109. BJS Open. 2022. PMID: 36218348 Free PMC article.
Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial.
Zwanenburg ES, Wisselink DD, Klaver CEL, Brandt ARM, Bremers AJA, Burger JWA, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Wiezer MJ, Tuynman JB, Tanis PJ; COLOPEC trial collaborators. Zwanenburg ES, et al. Among authors: hemmer phj. Br J Surg. 2022 Mar 15;109(4):315-318. doi: 10.1093/bjs/znab467. Br J Surg. 2022. PMID: 35136941 Clinical Trial. No abstract available.
54 results